Drug Designing & Intellectual Properties International Journal · 2018 · 40 citations · 8 references
PharmacySupply Chain ManagementGood Manufacturing PracticePharmaceutical ManufacturingPharmaceutical RegulationDrug Distribution SystemsMedication ProcurementPharmaceutical DistributionSupply ChainsDrug Supply Chain ManagementDrug Supply Chain RegulationDrug Supply Chain StrategyMedication SourcingMedicine Supply ChainsPharmaceutical LogisticsPharmaceutical Supply ManagementSupply Of Pharmaceutical Products
The top priority in any health system is delivering of medicine as a strategic product. In the present context of a health-conscious society, management of pharmaceutical supply chains has become more complex because it involves the life-saving interest of human being and requires the participation of different stakeholders such as pharmaceutical manufacturers, wholesalers, distributors, customers, information service providers and regulatory agencies. Limited research is available in the area of pharmaceutical supply chains. Pharmaceutical companies, a most important player of the drug supply chain, are subject to many risks. These risks interrupt the quantity and quality of supply of medicine and their delivery to the accurate place and customers and at the correct time.
8